Device Trial Radar · NCT04275089
Early Feasibility Study of the Reia Vaginal Pessary
Last checked: Nov 20, 2026Latest source record: Jul 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
15
Actual
Start
Nov 5, 2020
Primary completion
Jan 20, 2021
Study completion Jan 20, 2021
Sponsor
- Lead sponsor
- Reia, LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 19, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Device feasibility
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an early feasibility open-label non-randomized trial to obtain preliminary information about the function and effectiveness of a novel vaginal pessary for the use in women who suffer from symptoms of pelvic organ prolapse (POP). Recruited patients will have Stage II POP or greater and will be current users of a legally marketed vaginal pessary. In a single visit, data will be collected on the performance and comfort of the subject's current pessary. After placement of a study pessary, comparative data will be collected between subject's current pessary and the study pessary on ability to support prolapse. The study pessary's function will be assessed under controlled circumstances. The patient will have her current pessary replaced at the conclusion of the visit. Results will be used to inform future design modifications of the study pessary.
Conditions
- Pelvic Organ Prolapse
- Prolapse
Interventions
Reia Vaginal PessaryDevice
Reia Vaginal Pessary
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Ability of the Study Device to be Retained During Valsalva Compared to the Ability of the Subject's Current Pessary to be Retained During Valsalva (Change in Distance Between Current Pessary and Study Pessary to Leading Edge to the Hymen)Time frame: During treatment - within 1 hour
- The Ability of the Study Device to be Retained Throughout Regular Activity (by Vaginal Examination)Time frame: During treatment - within 1 hour
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.